We next observed the effects of the J-1012 N-glycan on antigen-specific IFN-γ production several weeks after sepsis induction, because pre-clinical adjunctive immunotherapy involving IFN-γ seems to improve the hypo-immunoreactivity24. Here, IFNG is linked to Sepsis.